Azurity Pharmaceuticals, Inc. — a pioneer drug company that markets its FDA-approved oral vancomycin hydrochloride solution, FIRVANQ® — has sued Edge Pharma, LLC, an outsourcing facility operating pursuant to section 503B of...more
2/26/2020
/ Drug Compounding ,
Federal Food Drug and Cosmetic Act (FFDCA) ,
Food and Drug Administration (FDA) ,
Lanham Act ,
Manufacturers ,
Orange Book ,
Outsourcing ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Pharmacies ,
Prescription Drugs ,
Statutory Violations
We have all been there: An advertisement on television or a pop-up on Facebook beckons us to try the latest “visit-free,” “delivered to your door” treatment for a medical condition.
Originally published in Dermatology Times...more
1/22/2020
/ Direct to Consumer Sales ,
Drug Compounding ,
E-Commerce ,
Federal Trade Commission (FTC) ,
Food and Drug Administration (FDA) ,
Off-Label Promotion ,
Online Distribution ,
Online Platforms ,
Pharmaceutical Industry ,
Pharmacies ,
Popular ,
Prescription Drugs ,
Telemedicine